Astodrimer Sodium Nasal Spray versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blinded, Placebo-Controlled Trial

Background/Objectives: Dendrimer-based astodrimer sodium nasal spray was assessed for its ability to reduce SARS-CoV-2 load in outpatients with COVID-19, which remains a severe illness for vulnerable groups. Methods: This was a randomised, double-blind, placebo-controlled clinical investigation eval...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Stephen Winchester (Awdur), Alex Castellarnau (Awdur), Kashif Jabbar (Awdur), Meera Nadir (Awdur), Kapila Ranasinghe (Awdur), Xavier Masramon (Awdur), George R. Kinghorn (Awdur), Isaac John (Awdur), Jeremy R. A. Paull (Awdur)
Fformat: Llyfr
Cyhoeddwyd: MDPI AG, 2024-09-01T00:00:00Z.
Pynciau:
Mynediad Ar-lein:Connect to this object online.
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg